(Q33383029)

26 July 2017

1 reference

title

TTP/HUS and prognosis: the syndrome and the disease(s). (English)

1 reference

26 July 2017

Brian R Forzley

1

1 reference

26 July 2017

William F Clark

series ordinal

2

1 reference

26 July 2017

publication date

1 February 2009

1 reference

Kidney International. Supplement

26 July 2017

published in

1 reference

26 July 2017

issue

112

1 reference

26 July 2017

page(s)

S59-61

1 reference

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Hemolytic Uremic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Treating TTP/HUS with plasma exchange: a single centre's 25-year experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.623

7 January 2021

Identifiers

DOI

10.1038/KI.2008.623

1 reference

26 July 2017

1 reference